Sino Biopharmaceutical (SBMFF) Revenue
Sino Biopharmaceutical Revenue
Sino Biopharmaceutical had a revenue of 9.72B in the quarter ending Jun 30, 2026, with 0.00%. This bring the company's revenue in the last twelve months to 33.70B, Increased 2.85%. In the fiscal year ending Dec 31, 2025, Sino Biopharmaceutical had annual revenue of 31.83B with 10.28% growth.
- Revenue (ttm)
- 33.70B
- Revenue Growth
- 14.23%
- P/S Ratio
- 0.34
- Revenue/Employee
- $1,393,926
- Employees
- 22,838
- Market Cap
- $10.94B
Revenue Chart
Sino Biopharmaceutical Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 31.83B | 2.97B | 10.28% |
| Dec 31, 2024 | 28.87B | 2.67B | 10.18% |
| Dec 31, 2023 | 26.20B | 173.25M | 0.67% |
| Dec 31, 2022 | 26.03B | -835.19M | -3.11% |
| Dec 31, 2021 | 26.86B | 3.21B | 13.59% |
| Dec 31, 2020 | 23.65B | -586.81M | -2.42% |
| Dec 31, 2019 | 24.23B | 3.35B | 16.02% |
| Dec 31, 2018 | 20.89B | 6.07B | 40.96% |
| Dec 31, 2017 | 14.82B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.